DPH4 Antibody

What is DPH4 and what cellular functions does it participate in?

DPH4, also known as ZCSL3, DNAJC24 (DnaJ homolog subfamily C member 24), or CSL-type zinc finger-containing protein 3, is a protein involved in multiple cellular functions. Its primary role is in diphthamide biosynthesis, a post-translational modification of histidine that occurs in translation elongation factor 2 (EEF2). This modification makes EEF2 susceptible to ADP-ribosylation by certain bacterial toxins, including diphtheria toxin and Pseudomonas exotoxin A (Eta) .

Beyond its role in diphthamide biosynthesis, DPH4 stimulates the ATPase activity of several Hsp70-type chaperones. This function is significantly enhanced when DPH4 binds to iron. The iron-bound form of DPH4 becomes redox-active and can function as an electron carrier in cellular processes . The protein contains a DNAJ domain, suggesting it may function as a co-chaperone in protein folding and cellular stress responses. The multifunctional nature of DPH4 makes it a subject of interest across various research fields, particularly in protein synthesis, cellular stress response, and bacterial toxin mechanisms.

How is the DPH4 antibody utilized in different experimental applications?

The DPH4 antibody has demonstrated efficacy in multiple experimental applications, making it a versatile tool for researchers studying this protein. According to available data, the antibody (such as ab246925) has been validated for several key techniques:

• Western Blotting (WB): For detecting DPH4 protein expression levels in cell and tissue lysates, providing quantitative information about protein abundance .

• Immunohistochemistry on paraffin-embedded tissues (IHC-P): For visualizing the spatial distribution of DPH4 in fixed tissue sections, as demonstrated in human duodenum tissue samples .

• Immunocytochemistry/Immunofluorescence (ICC/IF): For examining subcellular localization of DPH4 in fixed cells, as shown in PFA-fixed, Triton X-100 permeabilized A431 cells (human epidermoid carcinoma cell line) .

When designing experiments utilizing DPH4 antibodies, researchers should consider optimizing antibody concentration for each application. For instance, data indicates use at 4 μg/ml for ICC/IF applications and 1/50 dilution for IHC-P . Cross-reactivity testing with potentially related proteins may be necessary to ensure specificity in complex samples.

What is the relationship between DPH4 and translation elongation factor 2 (EEF2)?

DPH4 plays a crucial role in the post-translational modification of translation elongation factor 2 (EEF2), specifically in the conversion of a histidine residue (His-715) to diphthamide. This unique modification requires a pathway involving five enzymes (DPH1-5), with DPH4 being an essential component of this process .

The diphthamide modification of EEF2 has significant functional implications. When properly modified, the diphthamide residue becomes the target for ADP-ribosylation by bacterial toxins such as diphtheria toxin and Pseudomonas exotoxin A. This toxin-mediated ADP-ribosylation inactivates EEF2, inhibiting protein synthesis and ultimately leading to cell death .

In research contexts, the relationship between DPH4 and EEF2 has been demonstrated through direct sequence analysis. Mass spectrometry analysis has confirmed that in cells with reduced DPH4 expression, EEF2 contains an unmodified His-715 residue, while in cells with normal DPH4 expression, this histidine is modified to diphthamide . This relationship makes DPH4 an important factor in understanding mechanisms of toxin resistance and protein synthesis regulation.

What experimental evidence confirms DPH4's role in diphthamide biosynthesis?

Multiple lines of experimental evidence confirm DPH4's essential role in diphthamide biosynthesis:

• Gene expression correlation: Quantitative PCR (qPCR) analysis has shown that reduced DPH4 mRNA levels correlate with lack of diphthamide modification on EEF2 .

• Protein expression correlation: Immunoblot studies demonstrate that reduced DPH4 protein levels correspond to decreased diphthamide formation .

• Direct knockdown experiments: shRNA-mediated knockdown of DPH4 in HAL-01 cells resulted in a reduction in the amount of EEF2 that could be ADP ribosylated, conclusively demonstrating DPH4's functional role in the diphthamide synthesis pathway .

• Mass spectrometry evidence: MALDI-MS analysis of EF2 peptides has demonstrated that cells with low DPH4 expression contain EF2 with unmodified His-715 residues (m/z 1745.861), while cells with normal DPH4 expression show diphthamide-modified peptides (m/z 1828.908 and 1836.179) .

• Developmental necessity: Studies have demonstrated that DPH4 knockout in mice is embryonic lethal, highlighting the critical importance of this protein and the diphthamide modification pathway for normal development .

These multiple experimental approaches collectively establish DPH4's essential role in the diphthamide biosynthesis pathway and provide various methodologies for researchers to investigate this function.

How does DPH4 downregulation contribute to immunotoxin resistance?

DPH4 downregulation contributes to immunotoxin resistance through a precisely defined molecular mechanism focused on preventing toxin-mediated ADP-ribosylation of elongation factor 2 (EEF2). Research has demonstrated this mechanism in cell lines resistant to HA22, a recombinant immunotoxin composed of an anti-CD22 Fv fused to a portion of Pseudomonas exotoxin A .

The mechanism involves multiple steps:

• Reduced DPH4 expression prevents diphthamide modification of His-715 on EEF2.

• Without the diphthamide modification, EEF2 cannot be ADP-ribosylated by the toxin portion of immunotoxins like HA22.

• In the absence of ADP-ribosylation, EEF2 remains functional, protein synthesis continues unimpaired, and cell death is averted.

This has been experimentally validated through:

• Quantitative PCR showing decreased DPH4 mRNA in resistant cells

• Immunoblot analysis confirming reduced DPH4 protein levels

• Direct mass spectrometry analysis of EEF2 showing absence of diphthamide modification

• shRNA-mediated knockdown of DPH4 confirming that reduced DPH4 alone is sufficient to cause immunotoxin resistance

This resistance mechanism has significant implications for therapeutic applications of immunotoxins, particularly in acute lymphoblastic leukemia (ALL) treatment. Understanding this pathway provides potential strategies to overcome or prevent resistance, such as combining immunotoxins with epigenetic modifiers that maintain DPH4 expression .

What techniques can be used to analyze DPH4 methylation status?

Analysis of DPH4 methylation status, particularly in its promoter region, requires specialized techniques that can accurately detect and quantify CpG methylation. Based on research findings, the following methodological approaches are recommended:

• Bisulfite Conversion and Sequencing: This gold-standard approach involves treating DNA with bisulfite, which converts unmethylated cytosines to uracil while leaving methylated cytosines unchanged. Subsequent PCR and sequencing of the DPH4 promoter region (spanning positions -134 to +55 relative to the ATG start codon) can reveal the methylation status of individual CpG residues .

• Methylation-Specific PCR (MSP): Following bisulfite conversion, PCR with primers specific to either methylated or unmethylated sequences can provide a rapid assessment of DPH4 promoter methylation status.

• Pyrosequencing: This quantitative technique provides accurate measurements of methylation percentages at each CpG site following bisulfite conversion.

• Methylation Arrays: Genome-wide methylation arrays can analyze the DPH4 promoter region alongside multiple other gene promoters to determine whether methylation changes are gene-specific or part of a global epigenetic shift .

When analyzing DPH4 methylation, researchers should focus specifically on the CpG island that spans the transcriptional start site, as this region shows differential methylation correlating with DPH4 expression levels. Studies have demonstrated that hypomethylation corresponds to high DPH4 expression, while hypermethylation corresponds to low expression and immunotoxin resistance .

How can researchers detect the diphthamide modification on EEF2?

Detection of the diphthamide modification on elongation factor 2 (EEF2) requires specialized analytical techniques due to the unique nature of this post-translational modification. Based on research protocols, the following methodological approaches are recommended:

• ADP-Ribosylation Assay: This functional assay takes advantage of the specific ADP-ribosylation of diphthamide-modified EEF2 by diphtheria toxin or Pseudomonas exotoxin. Using radiolabeled NAD+ as a substrate for the toxin-catalyzed reaction, researchers can measure the incorporation of radioactivity into EEF2 to assess the presence of the diphthamide modification .

• Mass Spectrometry Analysis: This definitive approach involves:

  • Isolation of EEF2 by diethylaminoethyl (DEAE) chromatography and gel electrophoresis

  • Trypsin digestion of the EEF2 band

  • MALDI-MS analysis of the resulting peptides

  • Identification of characteristic mass shifts: unmodified His-715 peptide (m/z 1745.861) versus diphthamide-modified peptides (m/z 1828.908 and 1836.179)

• MS/MS Analysis: Tandem mass spectrometry provides sequence information that can directly confirm the modification status of His-715 in the peptide FDVHDVTLHADAIHR.

When conducting mass spectrometry analysis, researchers should be aware that the diphthamide modification can undergo fragmentation during sample preparation or analysis, resulting in loss of the trimethylamino group through elimination reactions . This fragmentation pattern can actually serve as a diagnostic marker for the presence of diphthamide.

What experimental approaches can reveal DPH4's role as a co-chaperone?

DPH4 contains a DNAJ domain, suggesting it functions as a co-chaperone in protein folding and cellular stress responses. To investigate this role experimentally, researchers can employ several complementary approaches:

• ATPase Activity Assays: Since DPH4 stimulates the ATPase activity of Hsp70-type chaperones, researchers can measure ATP hydrolysis rates in reconstituted systems containing purified Hsp70 proteins with and without DPH4. This stimulation is reported to be enhanced by iron-binding to DPH4 .

• Protein-Protein Interaction Studies:

  • Co-immunoprecipitation using DPH4 antibodies to identify interacting Hsp70 family members

  • Yeast two-hybrid screening to map interaction domains

  • Surface plasmon resonance to measure binding affinities and kinetics

  • FRET (Förster Resonance Energy Transfer) analysis for real-time monitoring of interactions in living cells

• Iron-Binding Analysis:

  • Iron chelation experiments to determine how iron availability affects DPH4's co-chaperone function

  • Spectroscopic methods to characterize the iron-bound form of DPH4

  • Site-directed mutagenesis of potential iron-binding residues to identify critical domains

• Redox Activity Assessment:

  • Electron transfer assays to measure the redox activity of iron-bound DPH4

  • Identification of electron transfer partners in cellular contexts

• Cellular Stress Response Studies:

  • Analysis of DPH4 expression and localization under various stress conditions

  • Functional comparison with other DnaJ family proteins

  • Assessment of client protein folding in DPH4-depleted versus DPH4-overexpressing cells

These methodological approaches can provide comprehensive insights into DPH4's functional role as a co-chaperone while distinguishing this activity from its better-characterized role in diphthamide biosynthesis.

How does epigenetic regulation of DPH4 impact experimental outcomes?

Epigenetic regulation of DPH4, particularly through CpG island methylation in its promoter region, has significant implications for experimental outcomes across multiple research contexts. This regulation mechanism creates several important considerations for researchers:

• Immunotoxin Resistance Development: In cell culture experiments involving immunotoxins like HA22, methylation of the DPH4 promoter can lead to resistance development. Research has demonstrated that cells with hypermethylated DPH4 promoters show decreased DPH4 expression, reduced diphthamide modification of EEF2, and consequent resistance to immunotoxins .

• Experimental Reversibility: The epigenetic nature of this regulation mechanism means that resistance can be reversible. Studies have shown that resistant cells grown without selection pressure can revert to sensitivity after approximately 4 months, with corresponding demethylation of the DPH4 promoter . This reversibility must be considered in long-term experiments.

• Epigenetic Modifier Effects: DNA methyltransferase inhibitors like azacytidine can prevent the emergence of resistant cells and restore sensitivity in resistant populations. Experimental data shows that combining azacytidine (300 nM) with immunotoxins like HA22 (500 ng/mL) prevents the emergence of resistant cells, while azacytidine alone only slows growth by approximately 17% .

• Promoter-Specific Nature: Research indicates that methylation changes affecting DPH4 are gene-specific rather than representing global hypermethylation. Analysis of 24 gene promoters commonly methylated in leukemia and lymphoma cell lines showed no correlation with DPH4 methylation status . This specificity must be considered when interpreting experimental results.

• miRNA Regulation Considerations: Studies have identified potential roles for specific miRNAs in regulating DNA methylation. For instance, miR-126 levels were found to be decreased 14.3-fold in resistant cell lines, although this did not directly correlate with DNMT1 RNA levels . This layer of regulation may influence experimental outcomes in certain contexts.

Understanding these implications allows researchers to design more robust experiments, anticipate potential confounding factors, and develop strategies to address epigenetic variables in their research protocols.